82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT

 

82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT. Curved multiplanar reformatted images at varying virtual monoenergetic imaging (VMI) levels (40-140 keV) show stenosis at each level. Percent diameter stenosis (PDS) decreased from 92.5% at 40 keV to 53.1% at 140 keV. Extent of calcium blooming artifacts decreased from 100.0% at 40 keV to 72.3% at 140 keV.


January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with virtual monoenergetic imaging (VMI) reconstruction can help overcome present limitations in stenosis quantification on coronary CTA.

“When performing coronary CTA by PCD CT, the selection of VMI level influences stenosis assessment in calcified and mixed plaque, thereby potentially impacting clinical decision-making,” wrote corresponding author Tilman Emrich, MD, from the department of diagnostic and interventional radiology at Germany’s University Medical Center in Mainz.

In this AJR accepted manuscript, a phantom containing two custom-made vessels (25% and 50% stenoses) underwent PCD CT acquisitions without and with simulated cardiac motion. A retrospective analysis was performed of 33 patients (7 female, 26 male; mean age, 71 years; 64 coronary artery stenoses) who underwent coronary CTA by PCD CT followed by invasive coronary angiography (ICA). Scans were reconstructed at nine VMI levels (40–140 keV). Percentage diameter stenosis was measured, and bias was determined from the ground-truth stenosis percentage in the phantom and ICA-derived quantitative coronary angiography measurements in patients. Extent of blooming artifacts was measured in the phantom and in calcified and mixed plaques in patients.

Ultimately, for coronary CTA performed by PCD CT, stenosis percentage and calcium blooming artifacts decreased with increasing VMI level in calcified and mixed plaque. Stenosis measurement exhibited lowest bias, using invasive angiography as reference, at 100, 140, and 40 keV for calcified, mixed, and non-calcified plaque, respectively.

“To our knowledge,” Emrich et al. added, “this study is the first in vivo study to investigate the influence of different VMI levels on stenosis quantification of PCD CT in comparison with ICA as the reference standard.”

For more information: www.arrs.org


Related Content

News | RSNA

Aug. 13, 2025 — Registration is now open for the RSNA 111th Scientific Assembly and Annual Meeting, the world’s leading ...

Time August 13, 2025
arrow
News | Breast Imaging

Aug. 1, 2025 — The American Roentgen Ray Society’s American Journal of Roentgenology (AJR) has published a clinically ...

Time August 04, 2025
arrow
News | Artificial Intelligence

July 22, 2025 — GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device ...

Time July 23, 2025
arrow
News | Breast Imaging

QT Imaging Holdings, Inc. has announced the launch of its latest QTviewer, version 2.8. QTviewer stores and displays the ...

Time July 21, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | PET-CT

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...

Time June 23, 2025
arrow
News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Cardiac Imaging

May 20, 2025 — Royal Philips has launched the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter ...

Time May 27, 2025
arrow
News | Pediatric Imaging

May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric ...

Time May 20, 2025
arrow
Subscribe Now